| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
501,776 | 523,785 | 126,536 | 57,883 | 36,364 |
| Cost of Revenue
|
-152,211 | -163,861 | -55,497 | -35,139 | -19,925 |
|
Gross Profit
|
349,565 | 359,924 | 71,039 | 22,744 | 16,439 |
| Selling, General and Administrative Expenses
|
-34,952 | -31,406 | -9,662 | -7,408 | -5,995 |
|
Operation and Maintenance Expenses
|
-337 | -337 | -160 | -125 | -144 |
|
Research and Development Expenses
|
-5,696 | -5,218 | -2,225 | -929 | -313 |
| Depreciation, Amortization and Depletion
|
-240 | -240 | -200 | -250 | -249 |
|
Operating Income/Expenses
|
-41,225 | -37,201 | -12,247 | -8,712 | -6,701 |
|
Total Operating Profit/Loss
|
308,340 | 322,723 | 58,792 | 14,032 | 9,738 |
| Total Net Finance Income/Expense
|
-31,158 | -1,567 | -31 | -334 | -339 |
| Net Investment Income
|
57,158 | 57,158 | 5,389 | -1,566 | -264 |
|
Non-Operating Income/Expenses, Total
|
26,000 | 55,591 | 5,358 | -1,900 | -603 |
|
Pretax Income
|
334,340 | 378,314 | 64,150 | 12,132 | 9,135 |
|
Provision for Income Tax
|
-31,045 | -31,509 | -4,376 | -1,425 | -841 |
|
Net Income from Continuing Operations
|
303,295 | 346,805 | 59,774 | 10,707 | 8,294 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
303,295 | 346,805 | 59,774 | 10,707 | 8,294 |
|
Non-Controlling/Minority Interests
|
-13,437 | -2,079 | -97 | -22 | -18 |
|
Net Income after Non-Controlling/Minority Interests
|
289,858 | 344,726 | 59,677 | 10,685 | 8,276 |
|
Net Income Available to Common Stockholders
|
289,858 | 344,726 | 59,677 | 10,685 | 8,276 |
|
Diluted Net Income Available to Common Stockholders
|
289,858 | 344,726 | 59,677 | 10,685 | 8,276 |
| Basic EPS
|
2.88 | 3.45 | 0.62 | 0.11 | 0.09 |
| Diluted EPS
|
2.88 | 3.45 | 0.61 | 0.11 | 0.09 |
|
Basic Weighted Average Shares Outstanding
|
101,790.49 | 99,915 | 96,816 | 96,595 | 96,595 |
|
Diluted Weighted Average Shares Outstanding
|
101,936.50 | 100,237 | 97,328 | 96,981 | 96,595 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
365,498 | 379,881 | 64,181 | 12,466 | 9,474 |
|
EBITDA
|
368,282 | 382,590 | 66,182 | 13,755 | 10,733 |
|
Normalized EBITDA
|
368,302 | 284,702 | 52,403 | 13,989 | 12,428 |
|
Normalized Income
|
303,313.14 | 257,069.90 | 46,934.93 | 10,913.51 | 9,832.95 |
|
Total Unusual Items
|
20 | -97,888 | -13,779 | 234 | 1,695 |
12/31/2022 - 2/1/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade